Introduction
MicroRNAs (miRNAs) are a class of~22 nucleotides that are single strand non-coding RNAs that typically repress target genes at posttranscriptional level. A large number of studies have implicated miRNAs in almost all kinds of human cancers, and altered miRNA levels can result in aberrant expression of gene products that may contribute to cancer development [1] [2] [3] .
Recent studies have found that miRNAs often form composite feedback or feedforward loops with their targets, which contributes to robustness of biological processes [4] , decreases noise in gene regulation systems [5] , and might provide a mechanism of high information flow for the coordinate and adaptable control of miRNA and transcription factor target regulons [6] . These feedback loops might function in normal development as well as in inflammatory response and cancer [7] [8] [9] [10] [11] [12] [13] .
In this study, we analysed the functional enrichment of miR-139 putative targets, suggesting that miR-139 might play important roles in cancer-related functions and Jun might play central roles in miR-139-mediated functions, and then showed that miR-139, down-regulated in human gastric cancer, might play tumour suppressive roles through regulating the expression of Jun, an important component of the activator protein-1 (AP-1) transcription factor. Conversely, we also observed that Jun could induce miR-139 expression, probably through a distant upstream regulatory region. Hence, we provide the first evidence that Jun is regulated by miR-139 and the Jun/miR-139 feedback loop might be involved in human gastric cancer.
Materials and methods

Plasmids
AP1-luc luciferase reporter construct was made by inserting AP1 responsive element fused to a minimal TA promoter into multiple cloning sites in pGL3-basic reporter construct (Promega, Madison, USA). For the expression of miR-139, genomic fragment of human miR-139 precursor was amplified by PCR and subcloned into pIRES2-EGFP (Clontech).
The C-Jun 3′-UTR was cloned into the pGL3-CM as previously described between the Bgl II and Mlu I sites [3] . Overlapping PCR was performed to mutate the miR-139 target site in the Smad4 3′-UTR, using two additional primers, and the products were subcloned into pGL3-CM. R (WT)-luc was constructed by cloning the distal region upstream of miR-139 into pGL3-promoter reporter construct, and R(ΔJunBS)-luc was obtained by mutating Jun binding site through overlapping PCR.
Cell culture and transfection
AGS (gastric carcinoma, ATCC CRL-1739), SGC-7901 (gastric carcinoma) and SNU-16 (gastric carcinoma, ATCC CRL-5974) were cultured in Roswell Park Memorial Institute formulation 1640 (RPMI-1640) supplemented with 10% fetal bovine serum. For transient transfections, the cells were transfected with the aforementioned constructs in 6-cm flasks, protein lysates and total RNAs were collected at the indicated time points. For stable transfection, SGC-7901 cells were transfected with the miRNA expression construct or corresponding control construct in 6-well plates and selected using G418.
Proliferation assay
SGC-7901, AGS and SNU-16 cells transfected as indicated were subject to MTT assay (Life technology) according to the manufacturer's recommendations. Experiments were repeated three times, and data represented as the mean of quadruplicate wells ± SEM.
Migration and invasion assays
Cells cotransfected with miR-139 and miR-139 inhibitors or corresponding controls were cultured to confluence and then wounded using a white pipette tip. Three wounds were made for each sample, and migration distance was photographed and measured at zero time, after 48 h and 60 h.
For cell invasion assay, cells were seeded on matrigel-coated polycarbonate membrane insert in a transwell apparatus and maintained in RPMI-1640. RPMI-1640 containing 10% FBS was added to the lower chamber. After incubation for 12 h at 37°C, cells on the top surface of the insert were removed and cells that migrated to the bottom surface of the insert were fixed and stained by crystal violet and then subjected to microscopic inspection.
Flow cytometry
For the quantification of apoptosis, the cells were washed in cold PBS, incubated with Annexin V-PE and 7-Amino-Actinomycin D (7-AAD) (Southern Biotech, Birmingham, AL, USA) for 15 min in the dark and analysed within 1 h. Flow cytometry was performed using a Fluorescence-Activated Cell Sorting (FACS) Calibur Flow Cytometer with CellQuest 3.0 software (BD Biosciences, San Jose, CA, USA) or winMDI software (V2.9; Purdue University, West Lafayette, USA). For the measurement of cell cycle, 2-3 × 10 6 cells were fixed in 70% cold ethanol, treated with RNase A and stained with propidium iodide (Sigma). All analyses were performed in triplicate, and 20,000 gated events/samples were counted.
Soft agar assays
Transfected cells were plated in 0.25% agar on top of 0.5% agar, both containing 10% FBS in RPMI-1640. After two weeks, colonies with 50 cells or more were counted.
Local tumour growth
Tumour cell suspensions (10 7 cells/100 μl PBS) of either overexpression or mock cell lines were inoculated into the thigh of female nude mice. 40 days after implantation, mice were killed and tumours were weighted and photographed.
Luciferase reporter assay
Luciferase reporter assays were performed as described [3] . Briefly, the reporter plasmids were co-transfected using lipofectamine 2000 reagent (Life technology) with the miR-139 expression plasmid or miR-139 antisense oligos and the vector phRG-TK (Promega), which expresses synthetic Renilla luciferase to normalize the transfection efficiency. Luciferase activities were measured using the Dual-Luciferase Reporter Assay reagent (Promega) on a LB 960 Centro XS3 luminometer (Berthold Technologies, GmbH & Co. KG, Bad Wildbad, Germany). Each experiment was performed in triplicate, and the data represent the mean ± SD of three independent experiments.
Real-time RT-PCR for miRNA and mRNA analysis
Total RNA was isolated with Trizol reagent (Life technology), and Reverse transcription was performed using with oligo dT primers and random N6 primers for mRNA and stem-loop RT primer for miRNA with Superior III RT supermix (Innogene biotech, Beijing, China). The real-time PCR primers used are available on request. Real-time PCR was performed using the IQ5 system (BioRad) with UltraSYBR Mixture (Innogene), and expression was quantified relative to a housekeeping gene GAPDH for mRNA and U6 for miRNA. All experiments were repeated at least three times.
Western blot
Western blots were carried out using antibodies against Jun (#9165, Cell Signalling Technology, Danvers, MA, USA), p21 (#2946, Cell Signalling Technology, Danvers, MA, USA), c-Myc (#9402, Cell Signalling Technology, Danvers, MA, USA), Cyclin D1 (#2978, Cell Signalling Technology, Danvers, MA, USA) β-Actin (A5316, Sigma) and GAPDH (CW0101, Cowin Biotech, Beijing, China).
ChIP-qPCR
ChIP was performed using EZ-Magna ChIP™ G-Chromatin immunoprecipitation Kit (Millipore, 17-409, Darmstadt, Germany) following manufacturer's guide with Jun antibody (Cell Signalling Technology, #9165) or IgG control (#2729, Cell Signalling Technology). ChIPed DNA was subjected to qPCR analyses using regulatory region primers (F: TCGGTGTCAGCATCACACAA; R: GGAGTGTGGGTGAGTCACTG) and miR-139 locus primers (F: CAGACTCCGGCTTCAGTTGT; R: AGGAGGCA GGAGCTGGAATA). To determine chromatin interaction frequency between miR-139 upstream regulatory element and miR-139 locus, 3C assay was preformed largely as described [14] . Briefly, SGC-7901 cells were cross-linked by 1% formaldehyde. After cross-linking, nuclei were isolated and digested with Pst I restriction enzyme (NEB). The digested nuclei were diluted and intra-complex ligated with T4 DNA ligase (NEB), after reverse cross-linking by proteinase K (Thermo Scientific), ligation frequencies of restriction fragments are analysed by PCR, using primers specific for the restriction fragments of interest (available upon request), all 3C-PCR products were validated by sanger sequencing. targets that cross proved by at least 2 methods were selected for further analyses. Gene ontology analysis and pathway enrichment analysis were done in DAVID website (http://david.abcc.ncifcrf.gov). The target-pathway network was analysed and visualized in cytoscape software.
Bioinformatic analysis
G g PU.1 G 1 H L h h h U K n n n no a a s f g m m m p a a a a a b c g g g g g g g h h h h h h h h s w CTCF1 CTCF_(SC-5916) s Rad21 G CTCF_(C-20) h TCF4 L MafK_(ab50322) H K CEBPB G 1 H L K h p p y NRSF m CTCF t GATA3_(SC-268) n c-Myc n Max G K g PU.1 G K Egr-1 K E2F6_(H-50) G ZEB1_(SC-25388) G TCF12 m CTCF n Max G BCL3 L FOSL2 U c-Jun K USF-1 L FOXA1_(SC-101058) L FOXA2_(SC-6554) L FOXA1_(C-20) h NRSF G L K USF-1 L USF2 t ZNF263 h NRSF K E2F6 U c-Fos K c-Myc K HEY1 K ETS1 K GATA2_(CG2-96) K TAF7_(SQ-8) K GABP U c-Jun K E2F6_(H-50) U GATA-2 K Egr-1 H CEBPB s GATA-2 H AP-2gamma H K E2F6 H n Max K E2F6_(H-50) K TAF1 H Mxi1_(bHLH) H Pol2 H Ini1 G 1 H L CTCF 1 Sin3Ak-20 g PAX5-C20 G H K SMC3_(ab9263) G YY1_(C-20) G 1 H L s Rad21 G Znf143_(16618-1-AP) 1 t CTCF_(SC-5916) K CTCFL_(SC-98982) G CTCF_(C-20) K ZBTB7A_(SC-34508) H BAF155
Statistical analysis
Student t tests were performed to assess the significance of treatments vs. controls. Significance of differences in miR-139 levels between normal and gastric cancer tissues was tested by Wilcoxon rank sum test. The relationship between the expression of miR-139 and Jun in gastric cells and tissues was determined using the Spearman rank correlation. P b 0.05 was considered statistically significant.
Result
MiR-139 negatively regulates Jun expression
Down-regulation of miR-139 has been reported in several kinds of human cancers [15, 16] , and therefore a tumour suppressive role was proposed for miR-139, however, its exact role and the underlying mechanisms remain elusive. Computational predictions, based on Starbase data from PAR-CLIP experiments [17] combined with pre-compiled miRNA target databases identified an array of genes as putative targets of miR-139. Pathway analysis on these candidate targets indicated cancer-related pathways as top pathways that miR-139 might regulate ( Supplementary Fig. S1A ), and gene ontology analysis indicated that miR-139 targets might play important roles in transcription regulation, cell proliferation and migration ( Supplementary Fig. S1B ). Interestingly, one of the candidate target Jun, a member of activator protein 1 (AP-1) family, was found to be in the centre of target-pathway (Figs. 1A and 1B ) and target-function networks (Supplementary Fig. S2 ). Importantly, all of the methods we used predicted Jun as a miR-139 putative target.
We therefore examined whether miR-139 could repress Jun expression. Indeed, protein levels of Jun were reduced upon miR-139 overexpression in SGC-7901, AGS and SNU-16 cells, which could be readily reversed by miR-139 inhibitors (Fig. 1C and Supplementary Figs. S5A  and S5B ). Inhibition of miR-139 induced c-Jun and its target c-Myc expression ( Supplementary Figs. S5C and S5D) . Meanwhile, miR-139 inhibited Jun-mediated AP-1 activity, as assessed by AP-1 responsive reporter assay (Fig. 1E) . We were also able to observe that expression of Jun canonical targets c-Myc, Baculoviral IAP Repeat-Containing 5 (BIRC5, Survivin) and Cyclin D1, were significantly down-regulated upon miR-139 overexpression, which could be rescued by Jun restoration ( Supplementary Fig. S5E-S5G) . Furthermore, computational analysis revealed that Jun 3′-UTR harbours one putative binding site for miR-139 which is conserved across various species, and this target site was also identified in a high throughput Ago PAR-CLIP study [18] (Fig. 1D) . To confirm the potential interaction experimentally, a reporter construct was made by sub-cloning human Jun 3′-UTR downstream of the firefly luciferase coding sequence, and cotransfected into SGC-7901 cells with miR-139-expressing construct and/or miR-139 inhibitors. Overexpression of miR-139 decreased luciferase activity as compared to negative controls, while miR-139 inhibitors increased luciferase activity and reversed miR-139-mediated repression; furthermore, mutation of the putative miR-139 binding site abolished the effects of miR-139 and miR-139 inhibitors on luciferase activity (Fig. 1F) . These findings suggested that miR-139 could regulate Jun expression through a conserved binding site on its 3′-UTR.
Jun positively regulates miR-139 transcription
In an attempt to explore the mechanisms underlining miR-139's regulation, we explored data from ENCyclopedia Of DNA Elements (ENCODE) project and found a putative regulatory element characterized by H3K4Me1 and H3K27Ac peaks located approximately 10 kb upstream of miR-139 locus, which harboured an AP-1 motif and also captured by Jun ChIP-seq inferred from ENCODE data (Fig. 2A) . Jun was confirmed to bind to the potential regulatory element by using ChIP-qPCR assay in both SGC-7901 and SNU-16 cells, strikingly Jun can also bind to miR-139 locus, around which there is no AP-1 motif (Fig. 2B and Supplementary Fig. S3A ). Public Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET) data indicated that this regulatory element loops to miR-139 locus. To confirm this physical chromatin interaction in gastric cancer cells, we preformed chromosomal conformation capture (3C) assay in SGC-7901 cells. Data shown in Fig. 2A suggests high frequency of cross-link between these two fragments, providing structure basis for Jun binding to miR-139 locus. Further, to validate the enhancer activity of this element, we subcloned it into pGL3 reporter construct, then co-transfected with Jun overexpression plasmid and/or treated with Phorbol-12-myristate-13-acetate (PMA), which induces both Jun level and activity. Reporter assay indicated that the regulatory element (R) conferred approximately 5 times luciferase activity compared to pGL3 negative control, and Jun could dramatically increase activity of this element, whereas when the Jun binding site was deleted (R(ΔJunBS)), the activity as well as Jun responsiveness to PMA was largely impaired (Fig. 2C) . Consistently, the gradually increasing Jun expression by ectopic transfection increased miR-139 expression in a dose dependent manner in two tested gastric cancer cells (Fig. 2D and Supplementary Fig. S3B ). These data indicate that Jun could induce miR-139, probably through upstream regulatory element, which in turn targets Jun for inhibition, thus forming a negative feedback loop.
Aberrant miR-139/Jun feedback loop in human gastric cancer
To establish a clinical implication for the miR-139/Jun feedback loop, we checked the expression of miR-139 and Jun in a set of pair-matched gastric cancer samples; as a result, Jun was up-regulated in 16 of 19 cancerous specimens examined. Importantly, increased Jun expression was significantly correlated with decreased miR-139 (Figs. 3A and 3B) (Spearman's Ρ = −0.753, P = 3.05 × 10−4), suggesting an involvement of miR-139/Jun feedback loop in human gastric cancer. Downregulation of miR-139 in gastric cancer tissue was also supported by previous microarray datasets and reports [19] (Fig. 3C) . We also determined levels of miR-139 and Jun in gastric cancer cell line SGC-7901, AGS and SNU-16, and again found an inverse correlation between expressions of these two genes ( Supplementary Fig. S4 ).
To explore the roles of miR-139/Jun feedback loop in human gastric cancer cells, we carried out experiments in SGC-7901, AGS and SNU-16 cells. We observed that while apoptosis was significantly higher ( Fig. 4A, Supplementary Fig. S6 ), cell proliferation, migration and invasion ability were significantly impaired in miR-139 restored cells (Figs. 4B, 4C and Supplementary Fig. S7 ), which could be reversed by miR-139 inhibitors, supporting a tumour suppressive role of miR-139 in gastric cancer. Importantly, miR-139 likely executes these functions largely by targeting Jun oncogene, as restored Jun expression abolished both the tumour suppressive effects and molecular changes caused by miR-139 overexpression (Fig. 4, Supplementary Fig. S5E-5G and Fig. S6 ). Next, soft agar assay was performed to test role of miR-139 in colony formation. Overexpression of miR-139 could reduce anchorage independent cell growth, while restoration of Jun could rescue this effect (Fig. 5A) . The tumour suppressive role of miR-139 was confirmed in xenograft tumour model, where overexpression of miR-139 resulted in significant smaller tumour growth (Figs. 5B and 5C ), which is coincident with increased levels of p21 (WAF/CIP1) and decreased levels of Jun and c-Myc (Fig. 5D) . Interestingly, the expression changes of miR-139 and Jun in xenograft tumour model are not as dramatic as in cell line, we reasoned that cells with high level of miR-139 and hence low level of Jun would lose competitive advantage in heterogeneous tumour mixture during the process of tumorigenesis, which is consistent with the fact that miR-139 was frequently reduced, and thus Jun expression increased, in clinical gastric cancer samples.
Discussion
MiR-139 is consistently reported to be downregulated in several kinds of tumours, and involved in invasion and metastasis of colorectal cancer and hepatocellular carcinoma by targeting Rho-Kinase 2 [16] and the type I IGF-IR [20] respectively. Here, we preformed functional enrichment analysis on putative miR-139 targets and suggested that miR-139 most likely plays roles in cancer related functions, and oncogenic Jun might play central roles in these complicated miR-139-function networks. Experimental data confirmed that miR-139 inhibits Jun expression and affects gastric cancer via targeting Jun. So it's proposed here that miR-139 exerts tumour suppressive roles by coordinately targeting an array of related oncogenes including Jun.
Previous studies have established that Jun plays essential roles in cell growth, survival, migration and invasion, exerting oncogenic roles in various cancers [21] [22] [23] [24] . Activity of Jun is also critical for the initiation and progression of gastric cancer [25, 26] . Chemical compounds and biological factors, such as Helicobacter pylori [27, 28] , often act in gastric cancer through regulating Jun, while its regulation by miRNAs in this disease has not been reported yet. Here we showed that miR-139, a miRNA down-regulated in human gastric cancer, could target Jun for expression inhibition, providing a novel level of regulation for Jun in gastric cancer.
Interestingly, we found that Jun could also induce miR-139 expression, probably through an upstream distant regulatory element, which co-localize spatially to miR-139 locus, in a dose dependent manner in gastric cancer cells. Thus, all these data are consistent with the notion that Jun forms a self-limiting feedback loop with miR-139, in which Jun induces miR-139 expression through a distal upstream regulatory element, while miR-139 represses Jun expression to ensure tight control of its oncogenic activity. This unilateral feedback loop is supposed to contribute to homeostasis between oncogenic Jun and tumour suppressive miR-139. Interestingly, despite the high level of Jun in gastric cancer cells, miR-139 stays in low expression level, given that miR-139 is often epigenetic or post-transcriptional inactivated [15, 29] , we speculate that negative regulatory mechanisms other than Jun induction may dominate the regulation of miR-139 in gastric cancer, which makes the cancer cells insensitive to the lost-controlled Jun expression. In addition to gastric cancer, deregulation of miR-139 and/or Jun was also reported in several kinds of human cancer besides gastric cancer [16, [30] [31] [32] , we therefore could expect a more general role of aberrant miR-139/Jun feedback loop in human tumorigenesis. In summary, our study expanded insights into the roles and regulation of miR-139 in gastric cancer, provided the first evidence for direct Jun-miRNA feedback loop in human cancers, which might contribute to our understanding of the complicated mechanisms underlying gastric cancer, and may enhance the development of new therapeutic regimens in treating this disease.
Funding
